The record

LegislationLegislation· Apr 2026
HR 2319 Passed House — in Senate

Sponsored by Brendan F. Boyle (D)

Women and Lung Cancer Research and Preventive Services Act of 2025

Orders a federal study of lung cancer in women and underserved groups, due in two years.

Tradeoff

Directs the federal health department to review lung cancer research gaps and recommend a national screening strategy and awareness campaign. No funding amount specified in the bill.

What's in it

See official bill text

Costs less than $500,000 over the 2025-2030 period, subject to .

The $500,000 is just the federal cost to produce required reports on lung cancer research and screening access — the policy's real value is in generating research and awareness data for women and underserved populations without direct federal spending on programs or benefits.

H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 · Aug 2025

Passed the House by on April 21, 2026 — sitting in the Senate.

  1. House

    Introduced

    (Mar 25, 2025)

  2. House

    Committee on Energy and Commerce(Mar 25, 2025)

  3. House

    The Committee on Energy and Commerce voted to send it to the floor

    Reported by (Apr 29, 2025)

    Committee report H. Rept. 119-382.

  4. House

    Passage of the bill

    Passed by (Apr 21, 2026)

    No individual votes were recorded.

  5. Senate

    Received from the House

    Received(Apr 22, 2026)